Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Outlines Path For Guidance On Clinical Decision Support Tools

This article was originally published in The Gray Sheet

Executive Summary

CDRH officials are looking for ways to better define when and how clinical decision support tools included in mobile health applications or medical software should face FDA regulation.

You may also be interested in...



Classifying Health IT Still Key Focus For Digital Health Regulation

Conceptual fuzziness still an issue with regulating health IT, observers agree.

Device Tax Threatens Mobile App Developers; For Now, Though, Uncertainty Reigns

Questions about how the medical device tax could impact software application developers emerged at a June 20 American Enterprise Institute workshop.

IBM Watson Exec Eyes Oncology Advisors Pilot

Dan Cerutti, general manager of IBM Watson commercialization, offered a status update June 5 on a health care application for the computer technology.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel